Skip to main content

Serostim News

FDA Medwatch Alert: Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death

[UPDATED 08/04/2011] FDA has determined that, at this time, the evidence regarding recombinant human growth hormone and increased risk of death is inconclusive. In its analysis of the SAGhE study, ...

FDA Medwatch Alert: Serostim [somatropin (rDNA origin) for injection]

Serono, Inc. became aware of a counterfeit lot of Serostim [somatropin (rDNA origin) for injection]. The counterfeit material has been packaged to appear as drug product lot number S810-1A1. This is...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Serostim patient information at Drugs.com